News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

USPTO Notice of Allowance Marks Major Achievement for Protelica's Series of VEGFR-2 Antibody Mimics


5/1/2013 11:52:40 AM

Staying up-to-date has never been simpler. Sign up for free job search tips!

HAYWARD, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- Crowning almost eight years of research and development Protelica, Inc., an innovator in the field of protein engineering, just received a notice allowance for "UNIVERSAL FIBRONECTIN TYPE III BINDING-DOMAIN LIBRARIES" (U.S. Patent Application No. 12/820,018), a patent for composition of matter on a novel series of VEGFR-2 antagonists.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Protelica
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES